Chemours Co. (CC)

The Chemours Co. stock has experienced significant growth, rising by 102.92% between April 4, 2025, and April 2, 2026, reaching a new 52-week high of $22.80 in early April 2026. In Q3 2025, Chemours reported flat year-over-year net sales of $1.5 billion with strong growth in Opteon™ Refrigerants. In Q4 2025, the company reported net sales of $1.3 billion and a net loss of $47 million. Chemours announced quarterly cash dividends and an upsized private offering of $700 million aggregate principal amount of 7.875% senior notes due March 15, 2034. Several financial institutions adjusted their ratings and price targets for Chemours. Insider sentiment for Chemours has been positive, with high-impact open-market purchases from insiders.

Demand seasonality for Chemours' products varies by segment. Sales for refrigerants generally fluctuate by season, with higher sales in the first half of the year. The Titanium Technologies segment experiences seasonality, with volumes decreasing in western markets during the fourth quarter. There is generally no significant seasonality for fluoropolymers.

The Chemours Co. is a global chemistry company operating within the Specialty Chemicals industry. Its business is structured around three primary segments: Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM). TSS focuses on refrigerants like Opteon™ and Freon™. TT produces Ti-Pure™ titanium dioxide pigment. APM offers high-end polymers and advanced materials under brands such as Nafion™, Teflon™, Viton™, and Krytox™. The company also has a non-reportable segment that includes Performance Chemicals and Intermediates, which provides industrial chemical products.

Chemours has a significant global presence, with over 60 manufacturing facilities, laboratory sites, joint ventures, and offices worldwide. The company serves customers in approximately 110 to 120 countries across North America, Latin America, Asia-Pacific, Europe, the Middle East, and Africa. Key regional offices are located in places such as Wilmington, Delaware, Alphaville, Mexico City, Geneva, Seoul, and Shanghai.

Chemours' brand reputation has been significantly influenced by ongoing environmental liabilities, particularly related to PFAS. Chemours, DuPont, and Corteva reached an agreement with the state of New Jersey to pay $875 million over 25 years to resolve environmental claims, including PFAS pollution. A new federal lawsuit alleged that Chemours' Washington Works plant continued to pollute nearby water with high levels of toxic PFAS chemicals. An accounting probe in early 2024 led to an overhaul of executive leadership, which likely impacted the company's governance reputation.

The ownership structure of The Chemours Co. is predominantly institutional, with institutional investors holding approximately 94.20% of the company's shares as of July 2025. Mutual funds constitute a significant portion of this institutional ownership, accounting for 64.27% of holdings in July 2025. Major institutional owners include BlackRock, Inc., The Vanguard Group, Inc., and State Street Corp. Individual ownership, including shares held by management and directors, stood at a modest 0.63% in July 2025.